Fortress Biotech, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Net Loss Per Common Share (Tables)

Net Loss Per Common Share (Tables)

12 Months Ended

Dec. 31, 2014

Calculation of Basic and Diluted Net Loss Per Share

A calculation of basic and diluted net loss per share follows:

	For the year ended December 31,
	2014		2013		2012
($ in thousands except share and per share amounts)
Historical net loss per share:
Numerator
Net loss	$	(20,386)	$	(37,158)	$	(27,610)
Denominator
Weighted-average common shares outstanding Denominator for basic and diluted net loss per share		36,323,596		30,429,743		21,654,984
Basic and diluted net loss per share attributed to common stockholders	$	(0.56)	$	(1.22)	$	(1.27)

Computations of Diluted Weighted Average Shares Outstanding

The following shares of potentially dilutive securities have been excluded from the computations of diluted weighted average shares outstanding as the effect of including such securities would be antidilutive:

	For the year ended December 31,
	2014		2013		2012
Warrants to purchase Common Stock		693,636		1,012,977		1,091,558
Options to purchase Common Stock		2,276,813		3,936,199		2,279,603
Unvested Restricted Stock		6,087,717		140,995
		9,058,166		5,090,171		3,371,161